Literature DB >> 6842189

Mechanism of uncoating of influenza B virus in MDCK cells: action of chloroquine.

M Shibata, H Aoki, T Tsurumi, Y Sugiura, Y Nishiyama, S Suzuki, K Maeno.   

Abstract

Exposure of influenza B virus-infected MDCK cells to chloroquine at the time of infection resulted in significant inhibition of infection. The appearance of input virus in the intracellular vesicles was not affected in the presence of the drug, but primary transcription of the virus genome did not occur. Chloroquine caused a rapid rise in the pH inside the lysosomes of MDCK cells, to 6.5 from the physiological pH 5.6. In contrast, exposure of infected cells incubated in acidic medium (pH 6.0) to chloroquine did not cause an increase in lysosomal pH and this low pH treatment during the chloroquine-sensitive phase was followed by virus production. Influenza B virus induced haemolysis of chick erythrocytes at low pH values (5.0 to 5.9) which was associated with cell-cell membrane fusion. It is likely that chloroquine prevents the uncoating of influenza B virus by increasing the lysosomal pH above the critical value required for inducing fusion between the virus envelope and the lysosomal membrane.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6842189     DOI: 10.1099/0022-1317-64-5-1149

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  21 in total

Review 1.  Influenza A Virus Nucleoprotein: A Highly Conserved Multi-Functional Viral Protein as a Hot Antiviral Drug Target.

Authors:  Yanmei Hu; Hannah Sneyd; Raphael Dekant; Jun Wang
Journal:  Curr Top Med Chem       Date:  2017       Impact factor: 3.295

2.  Influenza virus inhibits amiloride-sensitive Na+ channels in respiratory epithelia.

Authors:  K Kunzelmann; A H Beesley; N J King; G Karupiah; J A Young; D I Cook
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

3.  BK Virus replication in vitro: limited effect of drugs interfering with viral uptake and intracellular transport.

Authors:  Parmjeet Randhawa; Noush Afarin Farasati; Yuchen Huang
Journal:  Antimicrob Agents Chemother       Date:  2007-09-24       Impact factor: 5.191

4.  Aminoadamantanes with persistent in vitro efficacy against H1N1 (2009) influenza A.

Authors:  Antonios Kolocouris; Christina Tzitzoglaki; F Brent Johnson; Roland Zell; Anna K Wright; Timothy A Cross; Ian Tietjen; David Fedida; David D Busath
Journal:  J Med Chem       Date:  2014-05-15       Impact factor: 7.446

5.  Inhibition of influenza virus replication by targeting broad host cell pathways.

Authors:  Isabelle Marois; Alexandre Cloutier; Isabelle Meunier; Hana M Weingartl; André M Cantin; Martin V Richter
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

Review 6.  Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.

Authors:  Anwar M Hashem; Badrah S Alghamdi; Abdullah A Algaissi; Fahad S Alshehri; Abdullah Bukhari; Mohamed A Alfaleh; Ziad A Memish
Journal:  Travel Med Infect Dis       Date:  2020-05-06       Impact factor: 6.211

7.  Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses.

Authors:  Livia Di Trani; Andrea Savarino; Laura Campitelli; Sandro Norelli; Simona Puzelli; Daniela D'Ostilio; Edoardo Vignolo; Isabella Donatelli; Antonio Cassone
Journal:  Virol J       Date:  2007-05-03       Impact factor: 4.099

Review 8.  The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway.

Authors:  Frédéric Carrière; Sonia Longhi; Michel Record
Journal:  Biochimie       Date:  2020-05-30       Impact factor: 4.079

Review 9.  Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19.

Authors:  Li Zou; Lijun Dai; Xingyu Zhang; Zhaohui Zhang; Zhentao Zhang
Journal:  Arch Pharm Res       Date:  2020-08-01       Impact factor: 6.010

10.  New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?

Authors:  Christian A Devaux; Jean-Marc Rolain; Philippe Colson; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2020-03-12       Impact factor: 5.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.